INNOVIVA, INC. Other Revenue, Net (Deprecated 2018-01-31)
INNOVIVA, INC. (INVA) reported Other Revenue, Net (Deprecated 2018-01-31) of $24.51 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-27.
Discontinued › Income Statement › Other Income
us-gaap:OtherSalesRevenueNet · last filed 2012-02-27
- INNOVIVA, INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $5.36M, a 22.76% decline year-over-year.
- INNOVIVA, INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $6.43M, a 21.29% increase year-over-year.
- INNOVIVA, INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2011-06-30 was $6.39M, a 2.00% increase year-over-year.
- INNOVIVA, INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2011-03-31 was $6.33M.
- INNOVIVA, INC. other revenue, net (deprecated 2018-01-31) for fiscal 2011 was $24.51M, a 1.19% increase from fiscal 2010.
- INNOVIVA, INC. other revenue, net (deprecated 2018-01-31) for fiscal 2010 was $24.22M, a 0.62% decline from fiscal 2009.
- INNOVIVA, INC. other revenue, net (deprecated 2018-01-31) for fiscal 2009 was $24.37M.
| Period end | Other Revenue, Net (Deprecated 2018-01-31) 3 month | Other Revenue, Net (Deprecated 2018-01-31) 6 month | Other Revenue, Net (Deprecated 2018-01-31) 9 month | Other Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2011-12-31 | $5.36M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $11.79M derived: sum of 2 quarters · filed 2012-02-27 | $18.18M derived: sum of 3 quarters · filed 2012-02-27 | $24.51M 10-K · filed 2012-02-27 |
| 2011-09-30 | $6.43M 10-Q · filed 2011-11-02 | $12.82M derived: sum of 2 quarters · filed 2011-11-02 | $19.15M 10-Q · filed 2011-11-02 | $26.09M derived: sum of 4 quarters · filed 2012-02-27 |
| 2011-06-30 | $6.39M 10-Q · filed 2011-08-03 | $12.72M 10-Q · filed 2011-08-03 | $19.66M derived: sum of 3 quarters · filed 2012-02-27 | $24.96M derived: sum of 4 quarters · filed 2012-02-27 |
| 2011-03-31 | $6.33M derived: 10-K 12 month − 3 quarters · filed 2012-02-27 | $13.27M derived: sum of 2 quarters · filed 2012-02-27 | $18.57M derived: sum of 3 quarters · filed 2012-02-27 | $24.84M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-12-31 | $6.94M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $12.24M derived: sum of 2 quarters · filed 2012-02-27 | $18.51M derived: sum of 3 quarters · filed 2012-02-27 | $24.22M 10-K · filed 2012-02-27 |
| 2010-09-30 | $5.30M 10-Q · filed 2011-11-02 | $11.57M derived: sum of 2 quarters · filed 2011-11-02 | $17.28M 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $6.26M 10-Q · filed 2011-08-03 | $11.98M 10-Q · filed 2011-08-03 | ||
| 2009-12-31 | $24.37M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |